Column Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Column Capital Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12	Closed	-$2K	–	835
2021 Q3	$2K	Hold	12	–	–	﹤0.01%	650
2021 Q2	$2K	Hold	12	–	–	﹤0.01%	650
2021 Q1	$2K	Sell	12 -352	-97%	-$54.5K	﹤0.01%	639
2020 Q4	$54K	Buy	364 +352	+2,933%	+$49.7K	0.01%	257
2020 Q3	$2K	Hold	12	–	–	﹤0.01%	608
2020 Q2	$1K	Hold	12	–	–	﹤0.01%	809
2020 Q1	$1K	Hold	12	–	–	﹤0.01%	692
2019 Q4	$1K	Buy	+12	New	+$1.66K	﹤0.01%	710

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Column Capital Advisors's ZBH Position: Q4 2021 in Review

Column Capital Advisors sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 12 shares — an estimated $2K sold.

Column Capital Advisors first reported a position in ZBH in Q4 2019 and held it in 8 quarters. The position peaked at $54K in Q4 2020. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

Column Capital Advisors reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
Column Capital Advisors sold 12 Zimmer Biomet shares in Q4 2021, an estimated $2K.
Column Capital Advisors first reported a position in Zimmer Biomet in Q4 2019 and held it in 8 quarters.
Column Capital Advisors's Zimmer Biomet position peaked at $54K in Q4 2020.
998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Column Capital Advisors's 13F filing for Q4 2021, filed 7 Feb 2022.